Lab marker
hsCRP
high-sensitivity C-reactive protein · hs-CRP
A sensitive readout of low-grade systemic inflammation, an independent predictor of cardiovascular events.
What it measures
C-reactive protein is an acute-phase protein synthesised by the liver in response to interleukin-6. The high-sensitivity assay detects concentrations from 0.1 mg/L upward, making it useful for chronic low-grade inflammation rather than acute infection.
Reference context
3 guideline sources
Values fluctuate with acute illness, recent injury, intense exercise (24–48h), and high body fat. A single elevated reading deserves a repeat 2 weeks later, fasting, before action. Values >10 mg/L suggest acute inflammation rather than baseline cardiovascular risk and warrant clinical workup.
Population context: consult guideline targets below
Mechanism
Why moving this marker matters
Persistent low-grade inflammation contributes to endothelial dysfunction, plaque destabilisation, and insulin resistance. The CANTOS trial established a causal role for IL-1β/IL-6/CRP pathway inflammation in cardiovascular events independent of LDL.
Guideline targets
What major guidelines recommend
AHA/CDC 2003
<1.0 mg/L (low CV risk)
AHA/CDC 2003
1.0–3.0 mg/L (average CV risk)
AHA/CDC 2003
>3.0 mg/L (high CV risk)
How to measure
The test, where to get it, when to repeat
Method
Standard blood draw. Fasting not required. Use the high-sensitivity assay (hsCRP): the standard CRP assay is too coarse for risk stratification.
Where
GP request or private lab. Often bundled into 'longevity panels' and standard preventive bloodwork.
Typical cost
€10–25 private.
Fasting
Not required
When to test
AHA/CDC 2003
Optional addition to global risk assessment in intermediate-risk adults; repeat fasting if elevated to rule out transient cause.
ESC 2021
Routine use of circulating biomarkers (including hsCRP) for further risk refinement is not recommended.
Where to test
Independent labs offering this test
Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.
Randox Health
UK · EU · INTLClinic-based premium panels — wider biomarker breadth than home-test brands.
Visit Randox Health
Synlab
DE · EU · INTLEurope-wide medical lab network — referrals via partner GPs and direct-to-consumer programmes where offered.
Visit Synlab
Medichecks
UKUKAS-accredited home blood-test panels with GP-equivalent biomarker coverage.
Visit Medichecks
Thriva
UKApp-first subscription home testing, capillary draw, clinician-reviewed reports.
Visit Thriva
Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.
Context
Reading the numbers
Values fluctuate with acute illness, recent injury, intense exercise (24–48h), and high body fat. A single elevated reading deserves a repeat 2 weeks later, fasting, before action. Values >10 mg/L suggest acute inflammation rather than baseline cardiovascular risk and warrant clinical workup.
Caveats
BMI strongly influences hsCRP: excess adipose tissue is itself an IL-6 source. Hormonal contraception can elevate values.
Practices
What's been shown to influence this marker
In a 3-month PREDIMED substudy (772 adults at high cardiovascular risk), the Mediterranean diet with olive oil lowered CRP by about 0.5 mg/L compared with a low-fat diet; longer-term effects on hsCRP are less certain.
Reviews report modest hsCRP reductions with EPA/DHA supplementation, more consistently at higher doses (>2 g/day), but trial results are mixed.
HabitMediterranean dietary pattern
Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.
Why
The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.
Slot in your day
How to do it
How
Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.
Sticking with it
Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.
Markers this may influence
Evidence
Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.
GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)
- Estruch et al., NEJM 2018 (PREDIMED)
- Estruch R et al., Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts, N Engl J Med 2018
- Delgado-Lista J et al., Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial, Lancet 2022
- Rees K et al., Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst Rev 2019
- Dinu M et al., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials, Eur J Clin Nutr 2018
- Sofi F et al., Adherence to Mediterranean diet and health status: meta-analysis, BMJ 2008
- Psaltopoulou T et al., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis, Ann Neurol 2013
- Valls-Pedret C et al., Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial, JAMA Intern Med 2015
- Petersson SD, Philippou E, Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence, Adv Nutr 2016
- NICE guideline (2020): Acute Coronary Syndromes Guideline (NG185) — Secondary Prevention Visual Summary
- USPSTF guideline (2020): Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions
CautionSupplementOmega-3 (EPA + DHA)
EPA and DHA contribute to the normal function of the heart at a combined intake of at least 250 mg/day (EU authorised claim). Not needed by people who eat fatty fish twice or more a week.
Why
EPA and DHA are long-chain omega-3 fatty acids primarily from fatty fish. They support cell membrane function and are concentrated in brain tissue. NICE advises against omega-3 compounds to prevent cardiovascular disease. Supplements are an option for people who don't eat fatty fish regularly. Algae-derived versions exist for vegetarians.
How it works
Incorporated into cell membranes; competes with arachidonic acid in eicosanoid synthesis, shifting inflammatory signalling toward resolution.
Expected onset · ~12 weeks for steady-state membrane uptake
How to take
Dosage
1–2g combined EPA+DHA daily (check the label, total fish oil weight is misleading).
Timing
With a meal containing fat
On the label
Look for combined EPA+DHA per serving on the label, not just 'fish oil 1000mg'. Third-party tested for purity (IFOS, USP).
Studied in
People who eat fatty fish less than twice a week.
Safety
Markers this may influence
Evidence
EU authorised claim: EPA and DHA contribute to the normal function of the heart, at a combined intake of at least 250 mg a day. NICE guideline NG238 (2023) advises against offering omega-3 fatty acid compounds to prevent cardiovascular disease, with a narrow exception for icosapent ethyl added to statins in people with raised triglycerides, so the claim covers normal function, not disease prevention.
GRADE certainty: High — EU authorised claim
See also
Related markers
Take to your physician
Worth discussing
- Whether your hsCRP reflects measurable lifestyle factors (excess weight, smoking) before considering pharmacotherapy.
- If two consecutive readings exceed 3 mg/L, whether further workup is warranted.
- Whether your reading meaningfully changes your absolute CV risk estimate.
Sources
Cited literature
- [1]Pearson et al., AHA/CDC scientific statement: Markers of inflammation and cardiovascular disease(2003)
- [2]ESC 2021 Guidelines on cardiovascular disease prevention(2021)
- [3]Estruch et al., Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial (Ann Intern Med)(2006)
- [4]Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man.(2017)
Last reviewed October 2026
Keep reading